INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 145 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,750,000 | +9.7% | 168,800 | 0.0% | 0.09% | +17.3% |
| Q3 2021 | $2,507,000 | -25.6% | 168,800 | 0.0% | 0.08% | -27.2% |
| Q2 2021 | $3,371,000 | -13.5% | 168,800 | 0.0% | 0.10% | -16.3% |
| Q1 2021 | $3,896,000 | -50.0% | 168,800 | -46.5% | 0.12% | -53.4% |
| Q4 2020 | $7,786,000 | -34.6% | 315,230 | +9.8% | 0.26% | -45.9% |
| Q3 2020 | $11,902,000 | -11.3% | 287,075 | +2.5% | 0.49% | -16.6% |
| Q2 2020 | $13,412,000 | -25.4% | 279,942 | -2.0% | 0.58% | -41.0% |
| Q1 2020 | $17,984,000 | -50.1% | 285,639 | -1.8% | 0.99% | -34.5% |
| Q4 2019 | $36,028,000 | +76.4% | 290,731 | -5.6% | 1.51% | +71.0% |
| Q3 2019 | $20,427,000 | -9.1% | 307,828 | +9.0% | 0.88% | -15.0% |
| Q2 2019 | $22,467,000 | -28.5% | 282,354 | +0.5% | 1.04% | -28.2% |
| Q1 2019 | $31,422,000 | +12.2% | 280,904 | +1.1% | 1.45% | +8.0% |
| Q4 2018 | $28,014,000 | -29.1% | 277,944 | -11.1% | 1.34% | -24.9% |
| Q3 2018 | $39,503,000 | +22.9% | 312,627 | -18.4% | 1.79% | +40.8% |
| Q2 2018 | $32,151,000 | +39.3% | 383,166 | +2.1% | 1.27% | +36.3% |
| Q1 2018 | $23,084,000 | +27.3% | 375,223 | +20.9% | 0.93% | +34.1% |
| Q4 2017 | $18,128,000 | +34.3% | 310,300 | +33.4% | 0.70% | +36.0% |
| Q3 2017 | $13,497,000 | -32.9% | 232,544 | +40.1% | 0.51% | -29.7% |
| Q2 2017 | $20,100,000 | -8.1% | 166,023 | -14.1% | 0.73% | -2.2% |
| Q1 2017 | $21,870,000 | +6.6% | 193,369 | +2.4% | 0.74% | -2.4% |
| Q4 2016 | $20,524,000 | -42.2% | 188,904 | -12.4% | 0.76% | -41.4% |
| Q3 2016 | $35,511,000 | -12.4% | 215,752 | -24.1% | 1.30% | +13.4% |
| Q2 2016 | $40,554,000 | +7.9% | 284,230 | -2.9% | 1.14% | +8.9% |
| Q1 2016 | $37,601,000 | +42.4% | 292,687 | +65.5% | 1.05% | +53.2% |
| Q4 2015 | $26,408,000 | -13.8% | 176,817 | -4.3% | 0.69% | -3.5% |
| Q3 2015 | $30,632,000 | -33.4% | 184,688 | -3.1% | 0.71% | -24.6% |
| Q2 2015 | $46,024,000 | -31.6% | 190,670 | -20.1% | 0.94% | -35.5% |
| Q1 2015 | $67,335,000 | +43.0% | 238,760 | -20.9% | 1.46% | +50.4% |
| Q4 2014 | $47,076,000 | +291.5% | 301,769 | +494.0% | 0.97% | +326.8% |
| Q3 2014 | $12,024,000 | +0.0% | 50,800 | 0.0% | 0.23% | +7.5% |
| Q2 2014 | $12,021,000 | -28.2% | 50,800 | 0.0% | 0.21% | -26.4% |
| Q1 2014 | $16,753,000 | +382.9% | 50,800 | 0.0% | 0.29% | +380.0% |
| Q4 2013 | $3,469,000 | +101.0% | 50,800 | +103.2% | 0.06% | +106.9% |
| Q3 2013 | $1,726,000 | – | 25,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |